English
Select your language
Official EU languages:
Access to European Union law
EUR-Lex
Access to European Union law
This document is an excerpt from the EUR-Lex website
Use quotation marks to search for an "exact phrase". Append an asterisk (*) to a search term to find variations of it (transp*, 32019R*). Use a question mark (?) instead of a single character in your search term to find variations of it (ca?e finds case, cane, care).
Need more search options? Use the
Advanced search
Document 62024TO0455(01)
/
C-859/24 P(R)
Court of Justice
Status: Closed
Case on which the appeal is based: 62024TO0455(01)_1
Case on which the appeal is based: 62024TO0455(01)
Court of Justice
Status: Closed
Case on which the appeal is based: 62024TO0455(01)_1
Case on which the appeal is based: 62024TO0455(01)
DECISION
- Title
- Order of the Vice-President of the Court of 29 April 2025. Advanz Pharma Ltd v European Commission. Appeal – Interim relief – Medicinal products for human use – Orphan medicinal product for human use Ocaliva – Revocation of a conditional marketing authorisation – Application for suspension of operation of a measure – No urgency. Case C-859/24 P(R).
- ECLI identifier
- ECLI:EU:C:2025:315
- Applicant
- Individual
- Defendant
- European Commission, EU institutions and bodies
- Judge-Rapporteur
- von Danwitz
- Type of procedure
- Appeal - unfounded,Action for annulment,Application for interim measures
- Complementary documents:
29/04/2025
PROCEEDINGS
- Title
- Beslut av tribunalens ordförande av den 26 november 2024. Advanz Pharma Ltd mot Europeiska kommissionen. Mål T-455/24 R.
- ECLI identifier
- ECLI:EU:T:2024:863
- Applicant
- Privatperson
- Defendant
- Europeiska kommissionen, EU:s institutioner och organ
- Judge-Rapporteur
- Van der Woude
- Type of procedure
- Talan om ogiltigförklaring,Ansökan om interimistiska åtgärder - ogillad
- Complementary documents:
26/11/2024